Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

J. M. M. Evans; S. A. Ogston; A. Emslie-Smith; A. D. Morris

doi:10.1007/s00125-006-0176-9

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

J. M. M. Evans, S. A. Ogston, A. Emslie-Smith, A. D. Morris

Deanery of Molecular, Genetic and Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin.

Original language	English
Pages (from-to)	930-936
Number of pages	7
Journal	Diabetologia
Volume	49
Issue number	5
DOIs	https://doi.org/10.1007/s00125-006-0176-9
Publication status	Published - 2006

Access to Document

10.1007/s00125-006-0176-9

http://dx.doi.org/10.1007/s00125-006-0176-9

Cite this

@article{3cf4198bec864648b13ab1c6c39d74a0,

title = "Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin",

abstract = "The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin.",

author = "Evans, {J. M. M.} and Ogston, {S. A.} and A. Emslie-Smith and Morris, {A. D.}",

year = "2006",

doi = "10.1007/s00125-006-0176-9",

language = "English",

volume = "49",

pages = "930--936",

journal = "Diabetologia",

issn = "1432-0428",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

AU - Evans, J. M. M.

AU - Ogston, S. A.

AU - Emslie-Smith, A.

AU - Morris, A. D.

PY - 2006

Y1 - 2006

N2 - The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin.

AB - The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin.

U2 - 10.1007/s00125-006-0176-9

DO - 10.1007/s00125-006-0176-9

M3 - Article

SN - 1432-0428

VL - 49

SP - 930

EP - 936

JO - Diabetologia

JF - Diabetologia

IS - 5

ER -

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

Abstract

Access to Document

Fingerprint

Cite this